| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/14/2005 | US20050077176 Electrochemical cell |
| 04/14/2005 | DE10345011A1 Verwendung von an Metaring bindenden Substanzen zur Diagnose und Behandlung von Krebs Use of binding substances to Metaring for the diagnosis and treatment of cancer |
| 04/14/2005 | DE10343540A1 Coating reaction mixture containing target molecules onto microarray of interceptor molecules, provides molecules with protective groups which are removed after coating |
| 04/14/2005 | DE10343442A1 Quantitative detection of biological contaminants in complex cell mixtures, useful for testing cultures in food processing, by flow cytometry, using fluorescent antibody and magnetic particles |
| 04/14/2005 | DE10227042B4 Verfahren zum Nachweisen, Quantifizieren und/oder Charakterisieren eines Analyten A method for detecting, quantifying and / or characterization of an analyte |
| 04/14/2005 | DE10217102B4 Verfahren zur Charakterisierung von Primärtumoren A method for characterizing primary tumors |
| 04/14/2005 | CA2840691A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 04/14/2005 | CA2814613A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | CA2776997A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | CA2545639A1 Regulation of matrix metalloproteinases by psp94 family members |
| 04/14/2005 | CA2545248A1 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 04/14/2005 | CA2542021A1 Dmbt1 as a clinical marker and uses thereof |
| 04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
| 04/14/2005 | CA2541616A1 Sensor with increased biocompatibility |
| 04/14/2005 | CA2541240A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | CA2541059A1 Fluorescent probes for use in protein kinase inhibitor binding assay |
| 04/14/2005 | CA2541018A1 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis |
| 04/14/2005 | CA2540894A1 Gene expression profiles and methods of use |
| 04/14/2005 | CA2540875A1 Compositions and processes for genotyping single nucleotide polymorphisms |
| 04/14/2005 | CA2540857A1 Gene modulation by rb2/p130 expression |
| 04/14/2005 | CA2540837A1 Mammalian t1r3 sweet taste receptors |
| 04/14/2005 | CA2540681A1 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 04/14/2005 | CA2540622A1 Transgenic animals with serious disorders related to alzheimer's disease |
| 04/14/2005 | CA2540520A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
| 04/14/2005 | CA2540515A1 Low volume electrochemical biosensor |
| 04/14/2005 | CA2540508A1 Detection of immobilized nucleic acid |
| 04/14/2005 | CA2540275A1 Novel splice variants of human dkkl1 |
| 04/14/2005 | CA2540253A1 Hiv-dependent expression constructs and uses therefor |
| 04/14/2005 | CA2540244A1 Methods and compositions for defining gene function |
| 04/14/2005 | CA2539535A1 Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof |
| 04/14/2005 | CA2538994A1 Methods, compositions, and kits for detecting cryptosporidium pathogens |
| 04/14/2005 | CA2538094A1 Computer software and algorithms for systems biologically linked to cellular phenotype |
| 04/14/2005 | CA2537668A1 Methods and compositions for the diagnosis of sepsis |
| 04/14/2005 | CA2537326A1 C1q related protein |
| 04/14/2005 | CA2536303A1 Attachment of molecules to surfaces |
| 04/14/2005 | CA2530789A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 04/14/2005 | CA2526690A1 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 04/14/2005 | CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/13/2005 | EP1522859A1 On-Board-Control for test elements |
| 04/13/2005 | EP1522853A1 Dna microarray having standard probe and kit containing the array |
| 04/13/2005 | EP1522845A1 Method for assay of analyte by adjustment of chemiluminescence |
| 04/13/2005 | EP1522599A1 Use of metaring binding substances for diagnosis and treatment of cancer |
| 04/13/2005 | EP1522598A2 Expression profiles in adult and fetal organs |
| 04/13/2005 | EP1522597A1 Nucleic acid amplification method |
| 04/13/2005 | EP1522596A2 A method for the analysis of activation pathways controlled by neurotransmitters |
| 04/13/2005 | EP1522595A2 Oligonucleotides, methods and system for the detection of microbial antibiotic-resistence-inducing genes via real-time PCR |
| 04/13/2005 | EP1522594A2 Methods and kits for investigating cancer |
| 04/13/2005 | EP1522593A1 Method of decomposing protein with sulfonic acid compound |
| 04/13/2005 | EP1522592A1 Method of measuring glucose concentration and glucose sensor with the use of glucose dehydrogenase |
| 04/13/2005 | EP1522584A2 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 04/13/2005 | EP1522582A2 Optical sorting method |
| 04/13/2005 | EP1522581A2 Optical sortingmethod |
| 04/13/2005 | EP1522579A2 Hyaluronan synthase gene and uses thereof |
| 04/13/2005 | EP1522039A2 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 04/13/2005 | EP1522037A2 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics |
| 04/13/2005 | EP1521969A2 Quantitative analysis via isotopically differentitated derivatization |
| 04/13/2005 | EP1521961A2 Characterization of biochips containing self-assembled monolayers with maldi-tof-ms |
| 04/13/2005 | EP1521960A1 Enzyme electrodes and method of manufacture |
| 04/13/2005 | EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/13/2005 | EP1521848A1 Method of determining the copy number of a nucleotide sequence |
| 04/13/2005 | EP1521847A2 Marker genes for determining renal toxicity |
| 04/13/2005 | EP1521846A2 Serrs reactive particles |
| 04/13/2005 | EP1521845A1 Method for detecting increased susceptibility to tumours |
| 04/13/2005 | EP1521844A2 Identification of specific human chondrocyte genes and use thereof |
| 04/13/2005 | EP1521843A2 Method for chemiluminescent detection |
| 04/13/2005 | EP1521842A1 Electrochemical sensing using an enzyme electrode |
| 04/13/2005 | EP1521841A1 Method for identifying individual active entities from complex mixtures |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521831A2 Transgenic animal expressing alzheimer's tau protein |
| 04/13/2005 | EP1521829A2 Target dna |
| 04/13/2005 | EP1521827A1 Modulation of cytochrome p450 reductase activity |
| 04/13/2005 | EP1521825A2 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521774A2 Truncated tau proteins |
| 04/13/2005 | EP1521772A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 04/13/2005 | EP1521594A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 04/13/2005 | EP1521587A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 04/13/2005 | EP1487261A4 Methods and compositions for pharmacological and toxicological evaluation of test agents |
| 04/13/2005 | EP1453973A4 Methods for determining transcriptional activity |
| 04/13/2005 | EP1443973A4 Kits and methods for determining the effectiveness of sterilization or disinfection processes |
| 04/13/2005 | EP1438425A4 69583 and 85924,novel human protein kinase family members and uses therefor |
| 04/13/2005 | EP1425414A4 Genetic markers for improved disease resistance in animals (nramp1) |
| 04/13/2005 | EP1414840A4 Genomics applications for modified oligonucleotides |
| 04/13/2005 | EP1242576B1 Stabilizing diluent for polypeptides and antigens |
| 04/13/2005 | EP1214101A4 Method for detecting and killing epithelial cancer cells |
| 04/13/2005 | EP1210441B1 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 04/13/2005 | EP1105728B1 Modulating multiple lineage kinase proteins |
| 04/13/2005 | EP1090143B1 Method for quantifying tgf-beta |
| 04/13/2005 | EP1082454A4 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy |
| 04/13/2005 | EP1074624B1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 04/13/2005 | EP1064398A4 Two-dimensional linkage study techniques |
| 04/13/2005 | EP1062365A4 Detection of fermentation-related microorganisms |
| 04/13/2005 | EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 04/13/2005 | EP0915897B1 Process for combining parallel oligonucleotide synthesis and preparation of oligomer chips |
| 04/13/2005 | EP0854935B1 Method for contiguous genome sequencing |
| 04/13/2005 | EP0774971B1 Synthetic peptide inhibitors of hiv transmission |
| 04/13/2005 | EP0689609B2 Process for typing hla-b using specific primers and probes sets |
| 04/13/2005 | CN1606696A Article handling system and method |
| 04/13/2005 | CN1606694A Methods for monitoring and treating amyotrophic lateral sclerosis |